Stifel Maintains Hold on RxSight, Lowers Price Target to $7
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $8 to $7.
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $8 to $7.